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Many biochemists would consider it ~fa~~onable 
to concentrate all their efforts on the detailed study 
of one pharmaceutically important molecule. Rather 
they would argue for a more fundamental pproach 
in their work in the hope that this might have a 
practical application in the treatment of disease. 
Nevertheless, the enormous industrial production of 
insulin for the treatment of diabetes has stimulated a
wide range of chemical, biophysical and pharmacolog- 
ical studies, leading to important developments in 
fund~e~t~ biochemistry* 
groups and formation of the correct disulphide 
bridges. An alternative mefhod involves an enzyme 
catalysed semisynthesis from porcine insulin which 
differs from human insulin by the replacement of
threonine by alanine at the B chain C-terminus, The 
methods developed by Carpenter and CanuvaMDavis in 
Berkeley and Gattner et al. in Aachen depend on the 
reversibility af trypsin digestion at either Bas-Bs3 
or B2s-Bw in the presence of excess peptides of the 
human sequence. 
Progress in this area has resulted from the fact that 
interest in insulin has brought ogether an inter- 
disciplinary group of research workers, including 
chemists, X-ray crystallographers, immunologists, 
pharmacologists and physicians. Much of this colla- 
borative activity has been due to the foresight and 
personality of Helmut Zahn in Aachen, in whose 
laboratory many hundreds of insulin analogues have 
been tailored to the requirements of the international 
scientific community concerned with the study of 
insulin. It was, therefore, quite appropriate that 
Aachen should be the meeting place for discussion of 
new developments in this area and the location for an 
international s~~s~urn, organised by Dietrich 
Brandenburg, on the chemistry, structure and function 
of insulin and related hormones. 
Certainly the most exciting new deve~o~ent has 
been the achievement of K. Itakura and his colleagues 
of the City of Hope National Medical Centre, 
California, in expressing the synthetic insulin gene in 
Eschenkhia cc& They have designed human insulin A 
and B genes from overlapping fragments of 29 oligo- 
deoxy ribonucleotides which are joined using T4 
DNA ligase. The synthetic genes were fused on a 
plasmid within the E. coli P-galactosidase g ne and 
preceded by a methionine codon. Transformation bf 
E. coli with the plasmid allowed the synthesis of 
hybrid poly~pt~des including the A and B chains, 
which could be easily excised with cyanogen bromide 
treatment, puriaed and combined to give insulin with 
irnrn~o~o~~~ and receptor activity. 
Several laboratories have developed the ability to 
synthesise insulin; new ideas in the synthesis of poly 
peptides have come as a result and were described at 
the symposium. The most difficult step is the correct 
pairing of the disulphide bridges. To this end Birr and 
coworkers have protected the cysteinyl mercapto 
functions of the A and B chains using three differing 
reagents which allow selective liberation of the SH- 
Much has been learnt of the action of insulin from 
the study of sequence variants from a wide variety of 
vertebrates, The cyclostome, the atlantic hagfish, is 
the most primitive species whose insulin has been 
studied in detail. Although this insulin does not form 
zinc hexamers, the dimeric molecule closely resembles 
that of porcine insulin. Falkmer and Emdin have 
shown that hagfish insulin release is stimulated by 
3 nM ghtcose but not by amino acids. Exogenous 
hagfish insulin stimuiates incorporation of [‘“et- 
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glucose and [ 14C] leucine into skeletal muscle protein 
and glycogen, but not in the liver. These observations 
indicate that only small changes in the regulatory 
mechanism of insulin have occurred during the 500- 
million year span ofvertebrate evolution. Study of the 
relative affinity of hagfish insulin for the mammalian 
receptor based on competition of the unlabelled 
species for ‘2SI-labelled insulin has led to divergent 
reports. Emdin et al. previously reported a binding 
potency (23%) higher than the biological potency 
(5%) whereas Muggeo et al. reported a binding potency 
of S--10%. De Meyts has now shown that this dis- 
crepancy most probably results from the unusual 
kinetic properties of hagfish insulin receptor binding, 
which may not have been at equilibrium in the studies 
showing lower binding potency. Studies on lymphocyte 
receptors indicate a 25% relative binding potency. 
Similar unusual kinetics are found in another 
highly substituted insulin from the hystricomorph, 
casiragua. Horuk has shown that casiragua insulin is 
monomeric, has low biological potency, and is sub- 
stituted at Bzs and B2e, residues thought to be involved 
in receptor binding. Histricomorphs such as guinea 
pig and casiragua have insulins which have a relatively 
low receptor affinity even on their own tissues 
indicating that the receptor has been fairly conserved 
in evolution relative to the hormone itself. However, 
Lazarus et al. have found evidence from chemically 
modified insulins for some changes in the insulin 
receptor of hystricomorphs. Even the insulin of the 
old world hystrix, the porcupine, has an unusual 
structure which resembles that of guinea pig insulin in 
having an aspartate at Bas instead of arginine. 
Abnormal insulins may also be found in certain 
diabetic humans. Olefsky and his collaborators from 
Colorado and Chicago have demonstrated the 
existence of an insulin component (60% of the total) 
in the pancreas obtained during abdominal surgery 
of a patient with severe endogenous hyperinsulinemia. 
Although this abnormal insulin appears to have a 
leucine substituted for a phenylalanine at B24 or B25, 
many characteristics, including its apparent ability to 
antagonise the action of normal insulin, need to be 
elucidated; but this is the first unequivocal demon- 
stration that an abnormal insulin may play a role in 
diabetes. 
Variations in the sequences of insulins complicate 
insulin therapy by giving rise to immunological 
reactions, especially insulin allergy. However, the 
genetic constitution of the individual plays an impor- 
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tant role in the immune response. In fact, Keck and 
Momayesi have shown that in mice the immune 
response is initiated by a set of immunogenic deter- 
minants on insulin and a corresponding set of immune 
response genes present in the major histocompatibility 
complex and in the region coding for the immuno- 
globulins. Rosenthal et al. have shown that T cell 
response in strain 2 guinea pigs varies with the 
sequence A8-A10 whereas in strain 13 guinea pigs 
the response is to residues around B rc. However, no 
specific determinants unique to the insulin used for 
immunization were detected in the antibodies or B 
cells in these animals. In a survey of 115 patients with 
insulin allergy proliferative responses were found to 
vary. Some patients responded to the B chain C-ter- 
minus of beef and pork insulins, others to their 
C-peptidesand some to the bovine sequence A8-AIO. 
Protamine, used in an insulin complex for the treat- 
ment of diabetics, also appears to potentiate insulin 
allergy. 
In certain syndromes of severe insulin resistance 
circulating antibodies to the receptor are found. Kahn 
et al. have shown that these antibodies block insulin 
binding to their receptors, and have insulin-like effects 
on both muscle and adipose tissue but not the growth 
promoting effects such as thymidine incorporation 
into DNA in human fibroblasts. The monovalent Fan 
fragmentsare not active although they are competitive 
antagonists. The biological activities of the anti- 
receptor antibody require bivalence indicating the 
need for receptor aggregation in insulin action. 
Work on the characterisation and isolation of the 
insulin receptor has moved slowly. However, recent 
developments reported at the symposium in the use 
of analogues containing photosensitive groups such as 
4-azido-phenylacetyl are stimulating interest in this 
area again. Three groups have shown that photo- 
reactive insulin analogues can be labelled with “‘1 
and retain biological potency. The collaborative 
project of Brandenburg and Sonsken and their co- 
workers has shown that when activated by ultraviolet 
irradiation the photoprobes are bound covalently to 
insulin binding sites in rat liver plasma membrane 
fractions and isolated rat hepatocytes. SDS-poly- 
acrylamide gel electrophoresis, in the presence of 
mercaptoethanol, of either liver plasma membrane 
fractions or isolated hepatocytes showed that a 
polypeptide of app. mol. wt 130 000 was specifically 
labelled. Similar results were obtained by Yip and by 
Rees. The photolabelling is abolished by trypsin 
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treatment of the membranes whereas neuraminidase 
increased the electrophoretic mobility of the receptor 
proteins. 
The isolation and characte~~tion f two insulin- 
like growth factorsfIGF I and II) by Froesch, Humbel 
and coworkers in Zurich has given a great stimulation 
to the study of receptors pecifically concerned with 
aspects of insulin-like activity such as glucose 
transport and stimulation of proliferation of fibro- 
blasts. IGF I and IGF II have been isolated from a 
Cohn fraction of human plasma in homogenous form. 
The amino acid sequences are homologous to that of 
proinsulin, and Bedarkar and colleagues in collabora- 
tion with Humbel have shown that they may have an 
insulin-like fold, with a dist~bution of the surface 
residues consistent with the inability of IGF to bind 
anti-insulin antibodies. The models also predict hat 
both IGF I and IGF II might bind the insulin receptor, 
IGF II with the higher affinity. Indeed both IGF I 
and II share biological properties with insulin: on fat 
cells and lymphocytes, IGF competes with insulin for 
the insulin receptor; on fibroblasts and chondrocytes, 
insulin competes with IGF for the IGF receptor. De 
Meyts et al. have shown that on the lymphocyte 
insulin receptor IGF II has 1% of the potency of 
insulin in competing for ‘2SI-labelled insulin binding 
and IGF I only 2%, and both factors induce negative 
cooperativity. 
it is certainly rather larger than would be expected 
from a direct comparison with proinsulin. The hetero- 
geneity of relaxin-like polypeptides indic‘ates that the 
converting enzymes are certainly different and possibly 
less specific than those involved in processing pro- 
insulin. 
Schwabe has extended his studies on porcine 
relaxin to that of shark; this relaxin is larger than 
porcine relaxin, it has some amino acids, tyrosine, 
histidine and proline, not found in porcine relaxin, 
and it appears to have only two disulphide bridges. 
Shark relaxin resembles some peptides found in the 
purification of porcine relaxin and indicates that the 
evolution of relaxins may have involved greater varia- 
bility than that of insulin. 
Humbel et al. have shown that in serum IGF is 
bound to a mol. wt 40 000 glycoprotein which like 
IGF I is under growth hormone control. Preliminary 
evidence indicates that IGF may be produced in the 
liver. IGF I levels are raised in acromegalics, and very 
low in Laron dwarfs, hypopituitarism and liver cir- 
rhosis. These observations and radioimmunoassays 
comparing IGF I and II with somatomedins indicate 
that somatomedin C may be identical to IGF I 
whereas omatomedin A may be a mixture of the two 
ins~in-lye growth factors. 
The symposium aiso provided the opportu~ty to 
compare and contrast other pancreatic hormones 
with insulin. Epand reported the most recent experi- 
ments from his laboratory in Ontario which 
demonstrate hat all regions of the glucagon molecule 
are important for receptor binding. Studies of the 
ability of chemically modified glucagons to activate 
adenylate cyclase and to displace ‘251-labeled glucagon 
from specific membrane binding sites indicate that 
loss of ability to activate adenylate cyclase was at 
least as great as loss in receptor binding. However, for 
analogues modified towards the N-term~us, for 
example ~~-tr~itrophenyl g ucagon, the ability to 
activate cyclase is very much more impaired than the 
binding potency. Epand suggests hat glucagon may 
bind the receptor through a helical conformer, similar 
to that suggested previously by Sasaki et al. on the 
basis of X-ray data. However, Epand considers that 
the interaction may be relatively unspecific and 
involve hydrophobic interactions with lipids. Clearly 
glucagon receptor binding is more complicated than 
that for insulin as the glucagon molecule is more 
flexible and the active conformer is almost certainly 
induced at the receptor. 
Relaxin, an ovarian polypeptide hormone, has also The least studied of the pancreatic hormones is 
proved to be structurally related to insulin; with the 36 amino acid PP (pancreatic polypeptide) which 
substantial sequence homology and very probably, a is released into circulation after feeding and may act 
similar three-dimensional structure. The two chain as a satiety factor. Recent crystallographic studies 
structure of relaxin has led to the suggestion that it by Pitts et al. at Birkbeck College, London, of the 
may have a precursor prorelaxin. Preliminary results avian polypeptide has shown that this molecule 
obtained by Niall et al. translating luteal mRNA from appears to have a stable conformation involving a 
pregnant sow ovaries in an ascites tumour cell system polyproline II-like helix involving residues 1-9 
indicate the presence of a mol. wt 23 polypeptide including prolines at 2,s and 8 close-packed against 
which crossreacts ~m~ologically with relaxin. an a-helical region of residues 14-32. Like insulin, 
Although this molecule is probably a preprorelaxin the molecule forms dimers and further polymerises 
169 
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in the presence of zinc ions. 
In many ways the pancreatic polypeptides are the 
most carefully described of all polypeptide hormones, 
althou~ we are still some way from producing a
proper oral insulin or a useful glucagon antagonist 
both of which would transform the treatment of 
diabetes. But clearly this is still an active and produc- 
tive research area so that there may be hope for the 
future. 
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